Laddar...
Diabetes and cardiovascular disease: let’s push forward with translational research
Albeit advances in therapy have reduced morbidity and mortality in patients with diabetes, cardiovascular (CV) risk is far to be eradicated. This is partially due to the fact that breakthrough therapies have yet to be approved to counteract the atherosclerotic burden in this setting. Therefore, it i...
Sparad:
| I publikationen: | Cardiovasc Diagn Ther |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
AME Publishing Company
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609907/ https://ncbi.nlm.nih.gov/pubmed/26543828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2223-3652.2015.05.12 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|